chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I HAVE HAD IRREGULAR MENSTRUAL CYCLES SINCE RECEIVING THE FIRST DOSE OF COVID-19 MODERNA VACCINE 1/7/21.  MY MENSTRUAL CYCLES PRIOR TO RECEIVING THE FIRST DOSE HAVE CONSISTENTLY BEEN 26 DAYS EVERY CYCLE-- UNTIL RECEIVING FIRST COVID 19 MONDERNA VACCINE MY CYCLES ARE LASTING 30+ AND THIS IS EXTREMELY IRREGULAR
I21.4 - Non-ST elevation (NSTEMI) myocardial infarction R56.9 - Unspecified convulsions
Loss body feeling-weak-numb Headache Uses a wheelchair now Was hospitalized for 3days Her body shakes uncontrollably, and she can't stop it Has been diagnosed with Guillevin Barre Syndrome She sees a neurologist now to try to figure out the try to figure how to get her nerves to react, but nothing takes away the pain
Patient reported that her arm got very large and noticed 2 hours after administration when she took the bandage off that it was swollen and painful. Patient called on 10/10/2019, 2 days after getting the vaccine that she has noticed that it has gone done but is still swollen and red.
Started feeling a little dizzy around 8:15 at night, day of shot.  Got up to use restroom at 0300, still dizzy, a little worse.  Up at 0700 next day ,much worse.
6DEC chills, vomiting, diarrhea, t104, h/a; 11DEC cont w/h/a & diarrhea;
Right after vaccine was administered patient stood up and start feeling dizzy, as he was walking towards the exit he fell but didn't loose consciousness. When paramedics arrived they measured his blood pressure, it was very low (68/34). Patient was transported to hospital.
Patient reported to pharmacy on 6/9/19 with a 4-4.5 inch swollen red spot on her right arm that was firm to the touch, but otherwise well.  She was told to take 25 mg of benadryl during the day and 50 mg at night for two days and use an ice pack intermittently.  She called back later that same day to report that the swelling had gone down some and that the skin was a lighter shade of red, but still swollen.
Urinary tract infection; Her right arm got real sore, she could not lift her arm; Her right arm got real sore, she could not lift her arm; back hurting/lower part of back on right-hand side; soreness in legs; headache; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 04May2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored-program. A 66-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at 65 years old, dose 1, intramuscular, administered in arm right on 29Mar2021 (Batch/Lot Number: EP7533) (time given: 10:30 or 11:00) as 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received the first Pfizer COVID shot and she became sick after receiving it. She was supposed to go back on 19Apr2021 for the second dose but she was still recovering then. Patient was asking if she can she still get the second dose. Her right arm got real sore, she could not lift her arm. Then her back started hurting like it settled in lower part of back on right-hand side, she developed a real bad urinary tract infection (UTI) and soreness in legs, she could not even lay on her left side since she was in such pain. She ended up going to urgent care because she was in such pain with her back and arm. They gave her a steroid shot, antibiotic shot and oral antibiotics to take. Patient also experienced headache. She is feeling a lot better. She recovered completely around 26Apr2021. Did not require a visit to emergency room, required a visit to physician office.
Empty syringe inserted in pt, left deltoid.  Syringe withdrawn, error explained to pt.   Nurse filled a new syringe with vaccine and administered the dose in left deltoid.   Pt. recovered.
pt recvd vax;exp local rxn at inject site,erythema,swelling,pain,malaise,n;to er;tx w/ dph;exp anorexia,diaphoresis,fatigue,abd pain,urinary frequency,v;lab eval:occult blood & 2+ bacteria in urine screen;allergic rxn to vax per er MD;
ONE DAY AFTER GETTING HEPATITIS B SHOT, PATIENT DEVELOPED TIGHTNESS/SPASM/PAIN IN JAW...THIS LASTED FOR A FEW DAYS AND WAS RELIEVED AFTER TAKING NSAIDS/MUSCLE RELAXANTS.  HAD A SIMILAR PROBLEM AFTER SECOND DOSE OF HEP B.
Pain at injection site immediately, c/o decreased ROM, being seen by OHS MD at place of work.  Treatment with Acupuncture has provided decrease in pain.
Difficulty in range of motion and severe soreness in R arm after getting PNEUMOVAX 23 yesterday. Deltoid area swollen, red last night. Hot to touch. Advised pt this can sometimes occur with the vaccine. Advise icing the area to reduce inflammation. Ibuprofen as needed for pain. If it doesn't continue to get better, please have pt contact us and schedule an appt to be seen.
By 8 am, I recognized I realized I felt different - headache and foggy and tired. By 12 pm my headache became really severe - even when walking or chewing. My face was really hurting me; very tender by left eye. I felt so tired. I had to go home from work at 2:30. Felt very cold and I put on really warm clothes and got under three 3 blankets and I slept for three hours. I felt better by that evening, I slept normally that night.  Face was very swollen under my eyes - two days after vaccine. (I have filler under my eyes -  it's been a year since I had that put in.) Benadryl every six hours.  It took 12 hours for pain to go away and for it to decrease. But it did help. Everything resolved.
weakness; created cramp-like; shooting pain; muscle twinges; neurological damage; not sure if it was Guillain-barre syndrome; welts on her chest; tingling in her hands and legs / that started in her feet and went up her legs and arms; This case was reported by a consumer via other manufacturer and described the occurrence of guillain barre syndrome in a female patient who received Flu Seasonal TIV Quebec (FluLaval 2011-12 season) for prophylaxis.   On 28th September 2010, the patient received FluLaval 2011-12 season. On 28th September 2010, 30 min after receiving FluLaval 2011-12 season, the patient experienced guillain barre syndrome (serious criteria GSK medically significant), welts, tingling of extremity and nerve damage. On 26th November 2010, the patient experienced weakness, cramp, pain and muscle pain. On an unknown date, the outcome of the guillain barre syndrome, welts, tingling of extremity, weakness, cramp, pain, muscle pain and nerve damage were unknown.   It was unknown if the reporter considered the guillain barre syndrome, welts, tingling of extremity, weakness, cramp, pain, muscle pain and nerve damage to be related to FluLaval 2011-12 season.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the H1N1 Glaxo's Flulaval vaccine in her right arm on 28th September 2010 and within 30 minutes, she developed welts on her chest and tingling in hands and legs, which required a doctors visit the next day on the 29th September 2010. On 26th November 2010, 59 days later out of nowhere, the patient noticed that she started getting weakness, tingling that started in her feet and went up her legs and arms and spread quickly. It created cramp-like, shooting pains and muscle twinges, especially at night; that went on for months. Because of that, the patient had never gotten the flu, shingles, or pneumonia vaccine since 28th September 2010. The patient was not sure if it was Guillain-barre syndrome. The patient asked if anyone had suffered what she has went through and had anyone suffered neurological damage. The patient stated there was thimerosal in the H1N1 vaccine she received in 2010 that was used as a preservative and was wondering if the COVID vaccine had thimerosal. The patient asked how the H1N1 vaccine she received in 2010 that was inactivated different from the Covid 19 vaccine.
Pt recv vax on unspecified day; post vax pt exp irritable, restless, high pitched cry, clear nasal drainage, looking flushed
3 inch wide, heart shaped, red and risen mark where injection was about 9 days after administration. Itchy. Helped to take oral benadryl and to apply hydrocortisone ointment and ice to spot.
Tingling of tongue and roof of mouth immediate. Scratchy throat and cough followed. Had to take inhaler and benadryl.
tested positive for COVID; tested positive for COVID; This is a spontaneous report received from a contactable consumer (patient) via pfizer sponsored program.  A female patient of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number and expiry date: unknown), on an unspecified route of administration on 12Feb2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medication were not reported. The patient received the first dose of vaccine on 12Feb2021. On an unknown date in 2021, the patient tested positive for COVID. The patient had scheduled her second dose of vaccine on 06Mar2021 and was worried if she can continue for second dose. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Morning of 4/9/2021, mild headache. Also cough that lasted about 10 minutes. That night, headache become more severe, swelling, inflammation in right eye. Also burning in right eye, similar to peeling onions. Damp clothe to eye provided relief. Acetaminophen relieved pain.
MA gave pt GARDASIL when pt needed Tdap. Will have pt return for Tdap.
Pt recvd vax on 30MAR92 & devel redness & tenderness to lt arm on 31MAR redness disappeared by 1APR92;
heart problems; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age female patient who had heart problems while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient had heart problems (cardiac disorder) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (heart problems).  At time of reporting, the outcome was Unknown for the event heart problems.
pregnancy; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 15-May-2021 and the estimated date of delivery was 19-Feb-2022. In July 2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was not provided.  No treatment medications was not provided. The second dose of vaccine was scheduled on 10-Aug-2021.
Pt tested positive for covid-19 on 01/08/2021 and began declining to the point where he is actively dying.
Information has been received from a health professional concerning a 25 year old female who on 25-MAY-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast) (657622/0388U). On 25-MAY-2007 the patient experienced injection site reaction (redness, heat and pain at the injection site). Subsequently, the patient recovered from the injection site reaction. On 27-JUL-2007 the patient was vaccinated with the second dose of GARDASIL vaccine (yeast) (658490/0802U). On 27-JUL-2007 the patient experienced injection site reaction (redness, heat and pain at the injection site). Subsequently, the patient recovered from the the injection site reaction. On 26-NOV-2007 the patient was vaccinated with the third dose of GARDASIL vaccine (yeast) (659055/1522U). On 26-NOV-2007 the patient experienced injection site reaction (redness, heat and pain at the injection site), injection site arm is numb and unable to lift arm above shoulder. The patient's injection site reaction, injection site arm is numb and unable to lift arm above shoulder persisted. The reporter felt that injection site reaction (redness), injection site reaction (heat), injection site reaction (pain), injection site arm is numb and unable to lift arm above shoulder were not related to therapy with GARDASIL vaccine (yeast). Additional information has been requested. This is in follow-up to report previously submitted on 12/14/2007. Information has been received from a health professional concerning a 25 year old female who on 25-MAY-2007 was vaccinated with the first dose of GARDASIL vaccine (657622/0388U). On 25-MAY-2007 the patient experienced injection site reaction (redness, heat and pain at the injection site). Subsecuently, the patient recovered from the injectionsite reaction. On 27-JUL-2007 the patient was vaccinated with the second dose of GARDASIL (658490/0802U). On 27-JUL-2007 the patient experienced injection site reaction (redness, heat and pain at the injection site). Subsequently, the patient recovered from the injection site reaction. On 26-NOV-2007 the patient was vaccinated intramuscularly in the left deltoid with the third dose of GARDASIL vaccine (659055/1522U). On 26-NOV-2007 the patient experienced injection site reaction (redness, heat, and pain at the injection site), injection site arm is numb and unable to lift arm above shoulder. The patient's injection site reaction , injection site arm is numb and unable to lift arm above shoulder persisted. The reporter felt that injection site reaction, injection site arm is numb and unable to lift arm above shoulder were not related to therapy wiht GARDASIL vaccine. In information received on 09-JAN-2008, it was reported that the patient now 26 years old, has recovered from the injection site reaction, injection site arm is numb and unable to lift arm above shoulder. Additional information has been requested.
CHILLS; FEVER (TEMPERATURE IT WAS 101.1); This spontaneous report received from a patient concerned a 70 year old female. The patient's weight, height, and medical history were not reported. The patient experienced bad reaction when treated with influenza vaccine.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced chills, and fever (temperature it was 101.1). Laboratory data (dates unspecified) included: Body temperature increased (NR: not provided) 101.1 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever (temperature it was 101.1). This report was non-serious.
Pt given flu vax in outpt clinic, approx 3-1/2 hrs later devel tremors & fever. Drove to ER was admitted, tx /w fluids & meds, recovered uneventfully, D/C
Urticarial rash on bil upper extremities and on the trunk. No SOB, no angioedema. Treated with prednisone oral, BENADRYL oral and to ER.
Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021 at 9:17 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to MOD-2021-399960 (Patient Link).
tested positive for Covid 5 days afterwards; This non-serious case was reported by a consumer and described the occurrence of covid-19 virus test positive in a 64-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Concomitant products included levothyroxine, desvenlafaxine, acetylsalicylic acid (Aspirin) and nirmatrelvir + ritonavir (Paxlovid).   On 25-AUG-2023, the patient received Arexvy (intramuscular) .5 ml. On 28-AUG-2023, 3 days after receiving Arexvy, the patient experienced covid-19 virus test positive (Verbatim: tested positive for Covid 5 days afterwards).  The outcome of the covid-19 virus test positive was not resolved.   It was unknown if the reporter considered the covid-19 virus test positive to be related to Arexvy.     It was unknown if the company considered the covid-19 virus test positive to be related to Arexvy.   Additional Information: GSK Receipt Date: 02-SEP-2023 It was reported that 5 days after receiving Shingrix shot, the patient tested positive for Covid. The was currently taking Paxlovid for her Covid.  The patient stated that she was just wondering if that made her Arexvy injection less effective for preventing RSV vaccine. The patient mentioned Thank you in advance for responding and that she had paid dollar 295.60 for the shot, and would like to thought it was money well spent.
face turned flushed/a reddish color; Injection site hurt; A spontaneous report was received from a HCP concerning a male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced face turned flushed/a reddish color, Injection site hurt.  The patient's medical history, was not provided by the reporter, included . Concomitant medications reported included Losartan, Atorvastatin.   On 6/Jan/2021 patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20-2A) intramuscularly in the for prophylaxis of COVID-19 infection.   On 3/Feb/2021patient received their first of two planned doses of mRNA-1273 (Lot number: 028L20A) intramuscularly.  Action taken with mRNA-1273 in response to the events was not reported.   The events, face turned flushed/a reddish color, Injection site hurt and recovery was unknown.
pt recvd vax; mom said pt :won't stop screaming" up all noc; leg tender, no swelling or redness at site;
Child developed varicella disease; not mild per telephone call. Had various lesions all over body.
I had a miscarriage 2 days after the 1st dose of covid 19 vaccine. It was an early pregnancy 4-6 weeks. I started bleeding late April 3rd and continued, so I went to the ER at hospital on April 5, 2021.
PATIENT SEEN IN THE EMERGENCY ROOM WITH SHORTNESS OF BREATHE, INCREASED BLOOD PRESSURE, INCREASED HEART RATE, HEADACHE, RECTAL BLEEDING AND VOMITTING BLOOD. SYMPTOMS STILL UNRESOLVED.
Provider's notes: (Patient was having follow-up appt for dyspnea; so after those notes, she writes)  Additional information:  After OV yesterday, she slept most of the day, felt overpowering fatigue. Had frontal HA and took Tylenol.  Had soreness in both arms from the vaccines yesterday.  This morning noted swelling and redness in right arm so made appt. POC: Ice affected area three times a day for 20 minutes.  Go to ER if worsens over the weekend. I talked with patient after the OV.  She said onset was soon after the injections  she had gone straight home & became very fatigued went to bed.  Took 2 Tylenol ES for HA at 5:30PM & 10:30PM, otherwise slept most of the late afternoon, evening, & through the night.  Had one watery stool in the morning (day after shots).  Still feels fatigued but not as much. 11/26/13 at 4:27  I called patient & she said she is feeling back to normal.   Right arm still some tenderness but no welt as before.  Was feeling much better by Sunday evening.
Patient received  a dose of Menveo vaccine that was prepared with the powder vial and a sterile diluent instead of the liquid conjugate vial  from a medical assistant in the facility.  I contacted manufacturer to verify potential side effects and when to revaccinate. Per GSK patient can revaccinate as soon as possible without any time frame wait. Information regarding side effects, information was emailed to me to give to nursing staff involved.  Nursing staff involved will then contact patient and guardian to report, offer revaccination or appointment with provider to discuss further. Event will also be submitted.
My temperature started rising, and reached 102.8 degrees; sore throat; severe chills; severe chills where I couldn't stop shaking.; This is a spontaneous report from a contactable consumer (patient herself). A 75-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 02Sep2021 at 14:30 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE (age at vaccination was 75 years old) for covid-19 immunization, administered at a Pharmacy or Drug Store. The patient medical history was not reported. No known allergies. Concomitant medications included carvedilol (strength: 3.125 mg) at 3.125 mg and methylprednisolone (strength: 8 mg) at 8 mg, both taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient stated, on 03Sep2021 at 2.30 pm, approximately 24 hours later "I started to get a sore throat, then I got severe chills where I couldn't stop shaking. My temperature started rising, and reached 102.8 degrees. My normal temperature is always 97.7 degrees. When my temp reached 101.2 degrees my husband gave me one Tylenol (extra strength). When it reached 102.6 he gave me another one. I slowly started to warm up and my temperature slowly started to come down. By about 1:30 in the morning my temperature was down to 99.3 and I was feeling good enough to finally go to sleep. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Lab data included body temperature: 102.8 degrees, 101.2 degrees and 102.6 degrees on 03Sep2021; body temperature: 99.3 on 04Sep2021. Patient received Tylenol as treatment for pyrexia and no treatment was given for any other events. At the time of this report, the outcome of all the events was resolving.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Lingering chest pain and discomfort for several weeks. Off and on Left side chest pressure.  Elevated d-dimer on my physical exam on 03-31-2022 which resulted in very expensive Chest Pulmonary Embolism CT study on 04-01-2022.